Li Yan
Directeur Technique/Scientifique/R&D chez Brii Biosciences Ltd.
Postes actifs de Li Yan
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Brii Biosciences Ltd.
 Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC. | Directeur Technique/Scientifique/R&D | - | - |
Historique de carrière de Li Yan
Anciens postes connus de Li Yan
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BRII BIOSCIENCES LIMITED | Directeur Technique/Scientifique/R&D | 02/04/2018 | 05/07/2023 |
| GSK PLC | Corporate Officer/Principal | - | - |
Formation de Li Yan
| Peking University Health Science Center | Undergraduate Degree |
| University of Kansas | Doctorate Degree |
Statistiques
Internationale
| Chine | 3 |
| Etats-Unis | 3 |
| Royaume-Uni | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectorielle
| Consumer Services | 3 |
| Health Technology | 3 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BRII BIOSCIENCES LIMITED | Commercial Services |
| GSK PLC | Health Technology |
| Entreprise privées | 1 |
|---|---|
Brii Biosciences Ltd.
Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC. | Health Technology |
